Jincheng Du

机构：Union Hospital, Jilin University, Union Hospital

发表论文 7 篇 · 总被引 53 次 · h-index 3

代表论文

• RETRACTED: Berberine Maintains the Neutrophil N1 Phenotype to Reverse Cancer Cell Resistance to Doxorubicin (2020 · Frontiers in Pharmacology · 被引 40)
• Coagulation-Targeted TGF-β Signaling Pathway Inhibitor Nanomedicine for Inhibiting the Growth and Lung Metastasis of Breast Cancer (2024 · Nano Letters · 被引 6)
• Melatonin Maintains Macrophage M1 Phenotype to Reverse LPS-stimulated Tumor Immune Tolerance (2020 · 被引 3)
• Recent Advances in Prodrug‐Loaded Nanoparticles for Enhanced Immunotherapy Efficacy (2025 · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · 被引 2)
• Vascular disruption-triggered physiological cascade enables a therapeutic window for fibrin-hypoxia dual-targeting nanomedicines in solid tumors (2026 · Journal of Controlled Release · 被引 1)
• PD-L1-targeted polymer-peptide-immune nanomedicine synergizes radiotherapy for durable tumor control (2025 · Bioactive Materials · 被引 1)